scPharmaceuticals Statistics
Total Valuation
SCPH has a market cap or net worth of $174.64 million. The enterprise value is $128.00 million.
Important Dates
The last earnings date was Wednesday, November 13, 2024, after market close.
| Earnings Date | Nov 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SCPH has 50.04 million shares outstanding. The number of shares has increased by 11.46% in one year.
| Current Share Class | 50.04M |
| Shares Outstanding | 50.04M |
| Shares Change (YoY) | +11.46% |
| Shares Change (QoQ) | +19.43% |
| Owned by Insiders (%) | 4.24% |
| Owned by Institutions (%) | 45.93% |
| Float | 27.57M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.53 |
| Forward PS | 2.26 |
| PB Ratio | 5.48 |
| P/TBV Ratio | 5.59 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.23 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.08, with a Debt / Equity ratio of 1.71.
| Current Ratio | 8.08 |
| Quick Ratio | 6.67 |
| Debt / Equity | 1.71 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -7.79 |
Financial Efficiency
Return on equity (ROE) is -200.65% and return on invested capital (ROIC) is -46.24%.
| Return on Equity (ROE) | -200.65% |
| Return on Assets (ROA) | -34.44% |
| Return on Capital (ROIC) | -46.24% |
| Revenue Per Employee | $222,632 |
| Profits Per Employee | -$589,081 |
| Employee Count | 136 |
| Asset Turnover | 0.26 |
| Inventory Turnover | 0.73 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -36.00% in the last 52 weeks. The beta is 0.14, so SCPH's price volatility has been lower than the market average.
| Beta (5Y) | 0.14 |
| 52-Week Price Change | -36.00% |
| 50-Day Moving Average | 4.36 |
| 200-Day Moving Average | 4.69 |
| Relative Strength Index (RSI) | 32.31 |
| Average Volume (20 Days) | 502,150 |
Short Selling Information
The latest short interest is 4.13 million, so 8.25% of the outstanding shares have been sold short.
| Short Interest | 4.13M |
| Short Previous Month | 4.30M |
| Short % of Shares Out | 8.25% |
| Short % of Float | 14.98% |
| Short Ratio (days to cover) | 15.92 |
Income Statement
In the last 12 months, SCPH had revenue of $30.28 million and -$80.12 million in losses. Loss per share was -$1.96.
| Revenue | 30.28M |
| Gross Profit | 21.11M |
| Operating Income | -63.69M |
| Pretax Income | -57.71M |
| Net Income | -80.12M |
| EBITDA | -63.67M |
| EBIT | -63.69M |
| Loss Per Share | -$1.96 |
Full Income StatementBalance Sheet
The company has $92.63 million in cash and $52.50 million in debt, giving a net cash position of $40.14 million or $0.80 per share.
| Cash & Cash Equivalents | 92.63M |
| Total Debt | 52.50M |
| Net Cash | 40.14M |
| Net Cash Per Share | $0.80 |
| Equity (Book Value) | 30.71M |
| Book Value Per Share | 0.61 |
| Working Capital | 108.07M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$70.51 million and capital expenditures -$46,000, giving a free cash flow of -$70.56 million.
| Operating Cash Flow | -70.51M |
| Capital Expenditures | -46,000 |
| Free Cash Flow | -70.56M |
| FCF Per Share | -$1.41 |
Full Cash Flow StatementMargins
Gross margin is 69.72%, with operating and profit margins of -210.35% and -264.60%.
| Gross Margin | 69.72% |
| Operating Margin | -210.35% |
| Pretax Margin | -264.60% |
| Profit Margin | -264.60% |
| EBITDA Margin | -210.28% |
| EBIT Margin | -210.35% |
| FCF Margin | -343.08% |
Dividends & Yields
SCPH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.46% |
| Shareholder Yield | -11.46% |
| Earnings Yield | -46.68% |
| FCF Yield | -41.11% |
Analyst Forecast
The average price target for SCPH is $15.00, which is 329.80% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $15.00 |
| Price Target Difference | 329.80% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 89.75% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SCPH has an Altman Z-Score of -3.06 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.06 |
| Piotroski F-Score | 2 |